|
1
|
Ambient air pollution and atherosclerosis in Los Angeles.
|
Environ Health Perspect
|
2005
|
6.19
|
|
2
|
Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women.
|
Diabetes
|
2002
|
6.05
|
|
3
|
Pioglitazone for diabetes prevention in impaired glucose tolerance.
|
N Engl J Med
|
2011
|
4.28
|
|
4
|
Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men.
|
AIDS
|
2008
|
3.66
|
|
5
|
T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women.
|
J Infect Dis
|
2011
|
3.38
|
|
6
|
Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure.
|
AIDS
|
2005
|
3.07
|
|
7
|
Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection.
|
J Infect Dis
|
2012
|
2.64
|
|
8
|
Ambient air pollution and the progression of atherosclerosis in adults.
|
PLoS One
|
2010
|
2.53
|
|
9
|
Childhood air pollutant exposure and carotid artery intima-media thickness in young adults.
|
Circulation
|
2012
|
2.51
|
|
10
|
Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial.
|
Ann Intern Med
|
2014
|
2.48
|
|
11
|
Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women.
|
J Infect Dis
|
2012
|
2.16
|
|
12
|
Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults.
|
AIDS
|
2007
|
1.78
|
|
13
|
Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.
|
Menopause
|
2008
|
1.74
|
|
14
|
T cell activation predicts carotid artery stiffness among HIV-infected women.
|
Atherosclerosis
|
2011
|
1.64
|
|
15
|
Unopposed estradiol therapy in postmenopausal women: results from two randomized trials.
|
Obstet Gynecol
|
2007
|
1.61
|
|
16
|
Determinants of the effect of estrogen on the progression of subclinical atherosclerosis: Estrogen in the Prevention of Atherosclerosis Trial.
|
Menopause
|
2005
|
1.61
|
|
17
|
Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization.
|
Menopause
|
2011
|
1.55
|
|
18
|
Early onset of subclinical atherosclerosis in young persons with type 1 diabetes.
|
J Pediatr
|
2004
|
1.50
|
|
19
|
Herpes simplex virus type 2 (HSV-2) as a coronary atherosclerosis risk factor in HIV-infected men: multicenter AIDS cohort study.
|
Atherosclerosis
|
2012
|
1.50
|
|
20
|
Association between human immunodeficiency virus infection and stiffness of the common carotid artery.
|
Stroke
|
2010
|
1.44
|
|
21
|
Treatment-related changes in serum lipids and inflammation: clinical relevance remains unclear. Analyses from the Women's Interagency HIV study.
|
AIDS
|
2013
|
1.43
|
|
22
|
Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women.
|
J Clin Endocrinol Metab
|
2007
|
1.38
|
|
23
|
Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment.
|
J Acquir Immune Defic Syndr
|
2012
|
1.37
|
|
24
|
Heritability of subclinical atherosclerosis in Latino families ascertained through a hypertensive parent.
|
Arterioscler Thromb Vasc Biol
|
2002
|
1.35
|
|
25
|
Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection.
|
AIDS
|
2013
|
1.23
|
|
26
|
Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors.
|
Arterioscler Thromb Vasc Biol
|
2012
|
1.22
|
|
27
|
Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort.
|
AIDS
|
2014
|
1.19
|
|
28
|
Progression of carotid intima-media thickness in a contemporary human immunodeficiency virus cohort.
|
Clin Infect Dis
|
2011
|
1.18
|
|
29
|
A genome-wide scan for carotid artery intima-media thickness: the Mexican-American Coronary Artery Disease family study.
|
Stroke
|
2005
|
1.13
|
|
30
|
Metabolic syndrome and cognitive function in healthy middle-aged and older adults without diabetes.
|
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn
|
2008
|
1.13
|
|
31
|
Vitamin D levels and markers of arterial dysfunction in HIV.
|
AIDS Res Hum Retroviruses
|
2011
|
1.12
|
|
32
|
Effect of thiazolidinedione treatment on progression of subclinical atherosclerosis in premenopausal women at high risk for type 2 diabetes.
|
J Clin Endocrinol Metab
|
2004
|
1.12
|
|
33
|
Alterations in platelet function and cell-derived microvesicles in recently menopausal women: relationship to metabolic syndrome and atherogenic risk.
|
J Cardiovasc Transl Res
|
2011
|
1.11
|
|
34
|
Pharmacological treatment of insulin resistance at two different stages in the evolution of type 2 diabetes: impact on glucose tolerance and beta-cell function.
|
J Clin Endocrinol Metab
|
2004
|
1.10
|
|
35
|
Environmental tobacco smoke and carotid arterial stiffness.
|
Prev Med
|
2003
|
1.10
|
|
36
|
The phytoestrogen equol increases nitric oxide availability by inhibiting superoxide production: an antioxidant mechanism for cell-mediated LDL modification.
|
Free Radic Biol Med
|
2003
|
1.09
|
|
37
|
Persistence of the metabolic syndrome and its influence on carotid artery intima media thickness in overweight Latino children.
|
Atherosclerosis
|
2009
|
1.07
|
|
38
|
A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness.
|
AIDS
|
2015
|
1.05
|
|
39
|
Equol production changes over time in postmenopausal women.
|
J Nutr Biochem
|
2011
|
1.04
|
|
40
|
Elevated subclinical atherosclerosis associated with oophorectomy is related to time since menopause rather than type of menopause.
|
Fertil Steril
|
2004
|
1.01
|
|
41
|
Polyunsaturated fatty acids and cardiovascular disease: implications for nutrigenetics.
|
J Nutrigenet Nutrigenomics
|
2009
|
1.01
|
|
42
|
Association of subclinical atherosclerosis with lipid levels amongst antiretroviral-treated and untreated HIV-infected women in the Women's Interagency HIV study.
|
Atherosclerosis
|
2012
|
1.01
|
|
43
|
Association of hepatitis C virus and HIV infection with subclinical atherosclerosis in the women's interagency HIV study.
|
AIDS
|
2009
|
0.99
|
|
44
|
Intra-thoracic fat, cardiometabolic risk factors, and subclinical cardiovascular disease in healthy, recently menopausal women screened for the Kronos Early Estrogen Prevention Study (KEEPS).
|
Atherosclerosis
|
2011
|
0.99
|
|
45
|
Associations among vascular risk factors, carotid atherosclerosis, and cortical volume and thickness in older adults.
|
Stroke
|
2012
|
0.97
|
|
46
|
Urine accurately reflects circulating isoflavonoids and ascertains compliance during soy intervention.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
0.97
|
|
47
|
Cognition, mood, and physiological concentrations of sex hormones in the early and late postmenopause.
|
Proc Natl Acad Sci U S A
|
2013
|
0.97
|
|
48
|
Relation of Framingham risk score to subclinical atherosclerosis evaluated across three arterial sites.
|
Am J Cardiol
|
2008
|
0.95
|
|
49
|
Carotid artery intima-media thickness in college students: race/ethnicity matters.
|
Atherosclerosis
|
2011
|
0.95
|
|
50
|
Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study.
|
Breast Cancer Res
|
2005
|
0.94
|
|
51
|
Coronary heart disease and menopause management: the swinging pendulum of HRT.
|
Atherosclerosis
|
2009
|
0.94
|
|
52
|
Association of the diabetes gene calpain-10 with subclinical atherosclerosis: the Mexican-American Coronary Artery Disease Study.
|
Diabetes
|
2005
|
0.93
|
|
53
|
Role of annexin II in estrogen-induced macrophage matrix metalloproteinase-9 activity: the modulating effect of statins.
|
Atherosclerosis
|
2005
|
0.93
|
|
54
|
Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention Study.
|
Physiol Genomics
|
2012
|
0.93
|
|
55
|
Dysfunctional HDL and progression of atherosclerosis in HIV-1-infected and -uninfected adults.
|
Lipids Health Dis
|
2013
|
0.89
|
|
56
|
Effect of pioglitazone on progression of subclinical atherosclerosis in non-diabetic premenopausal Hispanic women with prior gestational diabetes.
|
Atherosclerosis
|
2007
|
0.88
|
|
57
|
Influence of age and obesity on serum estradiol, estrone, and sex hormone binding globulin concentrations following oral estrogen administration in postmenopausal women.
|
J Clin Endocrinol Metab
|
2009
|
0.88
|
|
58
|
Subclinical atherosclerosis is weakly associated with lower cognitive function in healthy hyperhomocysteinemic adults without clinical cardiovascular disease.
|
Int J Geriatr Psychiatry
|
2009
|
0.87
|
|
59
|
Associations between markers of inflammation and physiological and pharmacological levels of circulating sex hormones in postmenopausal women.
|
Menopause
|
2010
|
0.87
|
|
60
|
Potential role of platelet FcgammaRIIA in collagen-mediated platelet activation associated with atherothrombosis.
|
Atherosclerosis
|
2002
|
0.86
|
|
61
|
NOS1 methylation and carotid artery intima-media thickness in children.
|
Circ Cardiovasc Genet
|
2014
|
0.86
|
|
62
|
Associations between retinol-binding protein 4 and cardiometabolic risk factors and subclinical atherosclerosis in recently postmenopausal women: cross-sectional analyses from the KEEPS study.
|
Cardiovasc Diabetol
|
2012
|
0.86
|
|
63
|
17beta-Estradiol reverses shear-stress-mediated low density lipoprotein modifications.
|
Free Radic Biol Med
|
2006
|
0.85
|
|
64
|
Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis Trial.
|
Menopause
|
2005
|
0.85
|
|
65
|
Relation of progression of coronary artery atherosclerosis to risk of cardiovascular events (from the Monitored Atherosclerosis Regression Study).
|
Am J Cardiol
|
2005
|
0.85
|
|
66
|
Long-term effect of estrogen replacement on plasma nitric oxide levels: results from the estrogen in the prevention of atherosclerosis trial (EPAT).
|
Atherosclerosis
|
2005
|
0.84
|
|
67
|
Birth weight and carotid artery intima-media thickness.
|
J Pediatr
|
2012
|
0.84
|
|
68
|
Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS).
|
Fertil Steril
|
2013
|
0.83
|
|
69
|
Gonadotropin and sex steroid levels in HIV-infected premenopausal women and their association with subclinical atherosclerosis in HIV-infected and -uninfected women in the women's interagency HIV study (WIHS).
|
J Clin Endocrinol Metab
|
2013
|
0.82
|
|
70
|
Effect of antihypertensive therapy on progression of carotid intima-media thickness in patients with type 2 diabetes mellitus.
|
Am J Cardiol
|
2007
|
0.82
|
|
71
|
T-cell activation, both pre- and post-HAART levels, correlates with carotid artery stiffness over 6.5 years among HIV-infected women in the WIHS.
|
J Acquir Immune Defic Syndr
|
2014
|
0.82
|
|
72
|
Replication of calpain-10 genetic association with carotid intima-media thickness.
|
Atherosclerosis
|
2009
|
0.82
|
|
73
|
Mildly elevated TSH and cognition in middle-aged and older adults.
|
Thyroid
|
2009
|
0.82
|
|
74
|
Randomized controlled trial evidence that estrogen replacement therapy reduces the progression of subclinical atherosclerosis in healthy postmenopausal women without preexisting cardiovascular disease.
|
Circulation
|
2003
|
0.80
|
|
75
|
Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance.
|
PLoS One
|
2013
|
0.80
|
|
76
|
Association between monocyte Fcgamma subclass expression and acute coronary syndrome.
|
Immun Ageing
|
2004
|
0.80
|
|
77
|
Associations between urine excretion of isoflavonoids and cognition in postmenopausal women in the Women's Isoflavone Soy Health clinical trial.
|
J Am Geriatr Soc
|
2014
|
0.79
|
|
78
|
Ectopic fat and adipokines in metabolically benign overweight/obese women: the Kronos Early Estrogen Prevention Study.
|
Obesity (Silver Spring)
|
2013
|
0.79
|
|
79
|
Association of endogenous sex hormones with adipokines and ghrelin in postmenopausal women.
|
J Clin Endocrinol Metab
|
2014
|
0.79
|
|
80
|
Effect of isoflavone soy protein supplementation on endometrial thickness, hyperplasia, and endometrial cancer risk in postmenopausal women: a randomized controlled trial.
|
Menopause
|
2013
|
0.79
|
|
81
|
Carotid intima-media thickness (cIMT) cosegregates with blood pressure and renal function in hypertensive Hispanic families.
|
Atherosclerosis
|
2007
|
0.79
|
|
82
|
Subclinical atherosclerosis in Latino youth: progression of carotid intima-media thickness and its relationship to cardiometabolic risk factors.
|
J Pediatr
|
2011
|
0.78
|
|
83
|
Can menopausal hormone therapy prevent coronary heart disease?
|
Trends Endocrinol Metab
|
2008
|
0.78
|
|
84
|
Carotid artery intima-media thickness after raloxifene treatment.
|
J Womens Health (Larchmt)
|
2007
|
0.78
|
|
85
|
Blunted nocturnal cortisol rise is associated with higher carotid artery intima-media thickness (CIMT) in overweight African American and Latino youth.
|
Psychoneuroendocrinology
|
2013
|
0.77
|
|
86
|
Does elevated body mass modify the influence of postmenopausal estrogen replacement on atherosclerosis progression: results from the estrogen in the prevention of atherosclerosis trial.
|
Atherosclerosis
|
2003
|
0.77
|
|
87
|
The role of progestogens in regulating matrix metalloproteinase activity in macrophages and microglial cells.
|
Neurochem Res
|
2011
|
0.76
|
|
88
|
Physical activity and sex hormone levels in estradiol- and placebo-treated postmenopausal women.
|
Menopause
|
2011
|
0.76
|
|
89
|
Brachial artery vasoreactivity is associated with cross-sectional and longitudinal anatomical measures of atherosclerosis in postmenopausal women with coronary artery disease.
|
Atherosclerosis
|
2007
|
0.75
|
|
90
|
Response to: 'carotid intima-media thickness: assessment of sub-clinical atherosclerosis in HIV-infected patients'.
|
AIDS
|
2006
|
0.75
|
|
91
|
Telmisartan to reduce cardiovascular risk in older HIV-infected adults: a pilot study.
|
HIV Clin Trials
|
2015
|
0.75
|
|
92
|
Menopausal hormone therapy and prevention of chronic diseases: IMS members react to the recent JAMA paper.
|
Climacteric
|
2014
|
0.75
|
|
93
|
Estrogen therapy and coronary-artery calcification.
|
N Engl J Med
|
2007
|
0.75
|
|
94
|
Response to letter regarding article, “Childhood air pollutant exposure and carotid artery intima–media thickness in young adults”.
|
Circulation
|
2013
|
0.75
|
|
95
|
Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.
|
Menopause
|
2016
|
0.75
|
|
96
|
Drug firm conflicting interests. If only WHI was done well.
|
BMJ
|
2010
|
0.75
|
|
97
|
Response letter to Dr. Timo Strandberg.
|
J Am Geriatr Soc
|
2014
|
0.75
|
|
98
|
The ratio of plasminogen activator inhibitor type-1 activity to the concentration of plasminogen activator inhibitor type-1 protein in diabetes: adding insult to injury.
|
Coron Artery Dis
|
2002
|
0.75
|
|
99
|
Time from diagnosis of type 2 diabetes to initiation of insulin therapy is related to carotid artery intima-media thickness.
|
Atherosclerosis
|
2003
|
0.75
|
|
100
|
Menopausal hormone therapy for primary prevention: why the USPSTF is wrong.
|
Menopause
|
2017
|
0.75
|
|
101
|
Putting the latest data into practice: case studies and clinical considerations in menopausal management.
|
Cleve Clin J Med
|
2008
|
0.75
|